Dr. Gendelman discusses UNMC’s Parkinson’s breakthrough

Howard Gendelman, M.D., chairman of pharmacology and experimental neuroscience and director of the Center for Neurovirology and Neurodegenerative Disorders at UNMC, announced a new breakthrough in Parkinson’s disease research during a news conference on Wednesday.

Click on the images below to watch Dr. Gendelman and Monnie Lindsay, a Parkinson’s patient, speak about the breakthrough and what it means for patients.

Dr. Gendelman talks about what this breakthrough discovery means to the treatment of Parkinson’s disease.

Dr. Gendelman talks about his research on a Parkinson’s vaccine and the breakthrough his lab discovered in the treatment of Parkinson’s disease.

Lindsay discusses what it was like to be diagnosed with Parkinson’s disease.

Lindsay talks about the hope of a new treatment.

vXF